Showing results (61-70 of 607) with videos related to
Sort By:
Pageof 61
Alimentary Pharmacology & Therapeutics|July 14, 2026
Long-Term Safety and Efficacy of Obeticholic Acid in Patients With Primary Biliary Cholangitis: Final Results of the POISE Long-Term Safety ExtensionChristopher L Bowlus, Frederik Nevens, Kris V Kowdley, et al.Journal of Hepatology|October 22, 2022
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases†Frederik Nevens, Michael Trauner, Michael P MannsClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Risk of lymphoma in primary biliary cirrhosisChakri Panjala, Jayant A Talwalkar, Keith D LindorClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 20, 2004
Use of herbal supplements for chronic liver diseaseCynthia Levy, Leonard D Seeff, Keith D LindorThe American Journal of Gastroenterology|July 6, 2004
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic Fatty liver diseaseLeon A Adams, Keith D Lindor, Paul AnguloHepatology (Baltimore, Md.)|July 28, 2011
Cancer surveillance in patients with primary sclerosing cholangitisNataliya Razumilava, Gregory J Gores, Keith D LindorLiver International : Official Journal of the International Association for the Study of the Liver|April 4, 2017
Old and new treatments for primary biliary cholangitisDavid Chascsa, Elizabeth J Carey, Keith D LindorLiver International : Official Journal of the International Association for the Study of the Liver|March 22, 2021
Safety of fibrates in cholestatic liver diseasesAndres F Carrion, Keith D Lindor, Cynthia LevyExpert Review of Gastroenterology & Hepatology|September 11, 2018
Primary sclerosing cholangitis in children versus adults: lessons for the clinicAbimbola Adike, Elizabeth J Carey, Keith D LindorHepatology (Baltimore, Md.)|September 13, 2008
Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosisMarina G Silveira, Ayako Suzuki, Keith D LindorPageof 61